|4May 1, 6:12 PM ET

Chattopadhyay Sanat 4

4 · Merck & Co., Inc. · Filed May 1, 2025

Insider Transaction Report

Form 4
Period: 2025-04-29
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Transactions
  • Award

    Restricted Stock Unit

    2025-04-29+7,7917,791 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (7,791 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-04-29+35,46535,465 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28Common Stock (35,465 underlying)
Holdings
  • Common Stock

    (indirect: By GRAT February 2024)
    7,000
  • Common Stock

    (indirect: By GRAT April 2025)
    74,289
  • Common Stock

    (indirect: By GRAT May 2024)
    50,622
  • Common Stock

    (indirect: By GRAT February 2025)
    53,417
Footnotes (7)
  • [F1]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay February 2024 Grantor Retained Annuity Trust.
  • [F2]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay May 2024 Grantor Retained Annuity Trust.
  • [F3]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay February 2025 Grantor Retained Annuity Trust.
  • [F4]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay April 2025 Grantor Retained Annuity Trust.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F6]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F7]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT